Chang‐Ki Min
Sheba Medical Center(IL)St Mary's Hospital(GB)St. Paul's Hospital(KR)The Catholic University of Korea Seoul St. Mary's Hospital(KR)Seoul St. Mary's Hospital(KR)Catholic University of America(US)Catholic University of Korea(KR)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Hematopoietic Stem Cell Transplantation, Peptidase Inhibition and Analysis, Immune Cell Function and Interaction
Most-Cited Works
- → Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study(2017)350 cited
- → International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)(2020)265 cited
- → Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR(2018)257 cited
- → Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Patients With Previously Treated Multiple Myeloma: Three-year Follow-up of CASTOR(2019)148 cited
- → Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti–IL-6) in multiple myeloma(2014)140 cited
- → Intact-protein-based High-resolution Three-dimensional Quantitative Analysis System for Proteome Profiling of Biological Fluids